165 related articles for article (PubMed ID: 34748524)
21. Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis.
Gao L; Xu W; Li T; Zheng J; Chen G
Medicine (Baltimore); 2018 Jul; 97(29):e11556. PubMed ID: 30024551
[TBL] [Abstract][Full Text] [Related]
22. Performance of SPECT in the differential diagnosis of glioma recurrence from radiation necrosis.
Zhang H; Ma L; Wu C; Xu BN
J Clin Neurosci; 2015 Feb; 22(2):229-37. PubMed ID: 25443083
[TBL] [Abstract][Full Text] [Related]
23. Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis.
Zhang H; Ma L; Wang Q; Zheng X; Wu C; Xu BN
Eur J Radiol; 2014 Dec; 83(12):2181-2189. PubMed ID: 25452098
[TBL] [Abstract][Full Text] [Related]
24. Detection of glioma recurrence by ¹¹C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis.
Deng SM; Zhang B; Wu YW; Zhang W; Chen YY
Nucl Med Commun; 2013 Aug; 34(8):758-66. PubMed ID: 23670103
[TBL] [Abstract][Full Text] [Related]
25. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
26. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract][Full Text] [Related]
27. The Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the Differentiation of Pseudoprogression and Recurrence of Intracranial Gliomas.
Jing H; Yan X; Li J; Qin D; Zhang N; Zhang H
Contrast Media Mol Imaging; 2022; 2022():5680522. PubMed ID: 35935318
[TBL] [Abstract][Full Text] [Related]
28. Computed tomography
Li Y; Li L; Weng HL; Liebe R; Ding HG
World J Gastroenterol; 2020 May; 26(18):2247-2267. PubMed ID: 32476790
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
Du X; He Y; Lin W
Front Neurol; 2022; 13():882334. PubMed ID: 35812103
[TBL] [Abstract][Full Text] [Related]
30. The Diagnostic Accuracy of Magnetic Resonance Imaging in Restaging of Rectal Cancer After Preoperative Chemoradiotherapy: A Meta-Analysis and Systematic Review.
Wei MZ; Zhao ZH; Wang JY
J Comput Assist Tomogr; 2020; 44(1):102-110. PubMed ID: 31939890
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis.
Guo R; Cai L; Fan Y; Jin J; Zhou L; Zhang K
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):221-8. PubMed ID: 25986915
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of Susceptibility-Weighted Imaging and Dynamic Susceptibility Contrast Magnetic Resonance Imaging for Differentiating High-Grade Glioma from Primary Central Nervous System Lymphomas: Meta-Analysis.
Wu Y; Den Z; Lin Y
World Neurosurg; 2018 Apr; 112():e617-e623. PubMed ID: 29371168
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic performance of ultrafast MRI to differentiate benign from malignant breast lesions: a systematic review and meta-analysis.
Amitai Y; Freitas VAR; Golan O; Kessner R; Shalmon T; Neeman R; Mauda-Havakuk M; Mercer D; Sklair-Levy M; Menes TS
Eur Radiol; 2024 Mar; ():. PubMed ID: 38512492
[TBL] [Abstract][Full Text] [Related]
34. miRNA-21 may serve as a promising noninvasive marker of glioma with a high diagnostic performance: a pooled analysis of 997 patients.
Zhao X; Xiao Z; Li B; Li H; Yang B; Li T; Mei Z
Ther Adv Med Oncol; 2021; 13():1758835920987650. PubMed ID: 33613699
[TBL] [Abstract][Full Text] [Related]
35. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
[TBL] [Abstract][Full Text] [Related]
36. Role of magnetic resonance spectroscopy to differentiate high-grade gliomas from metastases.
Wang Q; Zhang J; Xu W; Chen X; Zhang J; Xu B
Tumour Biol; 2017 Jun; 39(6):1010428317710030. PubMed ID: 28631566
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
[TBL] [Abstract][Full Text] [Related]
38. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.
Wu LM; Xu JR; Gu HY; Hua J; Zhu J; Chen J; Zhang W; Hu J
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):252-64. PubMed ID: 23313568
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.
van Dijken BRJ; van Laar PJ; Holtman GA; van der Hoorn A
Eur Radiol; 2017 Oct; 27(10):4129-4144. PubMed ID: 28332014
[TBL] [Abstract][Full Text] [Related]
40. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
Li B; Li Q; Chen C; Guan Y; Liu S
Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
